Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Prostate Cancer
Sort By
Newest First
1 / 1
1 / 1
FDA Approves First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer
U.S. Food & Drug Administration
PR-M11-20-028
Dec 02, 2020
Oncology
FDA Will Use Real-Time Oncology Review for Prostate Cancer Drug
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M05-19-NI-012
May 10, 2019
Sun Pharma Announces USFDA Approval of YONSA® (abiraterone acetate) To Treat Metastatic Castration-Resistant Prostate Cancer In Combination With Methylprednisolone
Sun Pharma
PR-M05-18-NI-098
May 25, 2018
Clinical Trial
ERLEADA™ Significantly Reduced Risk of Prostate Specific Antigen (PSA) Progression in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
Janssen Pharmaceutical Companies
PR-M05-18-NI-086
May 23, 2018